SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-10-028733
Filing Date
2010-05-14
Accepted
2010-05-14 17:05:49
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 a10-10098_1s3.htm S-3 390358
2 EX-5.1 a10-10098_1ex5d1.htm EX-5.1 23849
3 EX-23.1 a10-10098_1ex23d1.htm EX-23.1 2913
4 GRAPHIC g100981cei001.jpg GRAPHIC 4395
5 GRAPHIC g100981bei001.jpg GRAPHIC 4395
  Complete submission text file 0001104659-10-028733.txt   431017
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-166859 | Film No.: 10834585
SIC: 2836 Biological Products, (No Diagnostic Substances)